IMRISneuro to be installed at Yale-New Haven Hospital

WINNIPEG, Jan. 12, 2009 /PRNewswire-FirstCall/ - IMRIS Inc. (TSX: IM) ("IMRIS"
or the "Company") today announced the sale of their flagship product,
IMRISneuro, to Yale-New Haven Hospital in New Haven, Connecticut, one of the
leading neuroscience centers in the U.S.
The only one of its kind in the world, IMRISneuro incorporates a movable
high-field MRI with a state-of-the-art integration platform, IMRISmatrix,
allowing the surgical team to scan, view and share critical patient
information during a procedure. At Yale-New Haven Hospital, the IMRISneuro
system will move between two operating theatres and a diagnostic center,
providing leading edge, multi-functional capabilities to the hospital's
neuroscience team.
"We are confident that in the hands of the surgeons at Yale-New Haven
Hospital, IMRISneuro can make a major contribution towards providing patients
with the highest standard of treatment and care," said David Graves, President
and CEO of IMRIS.
The purchase is contingent upon the receipt of a Certificate of Public Need
from the State of Connecticut.

About IMRIS

IMRIS (TSX: IM) is a global leader in providing fully integrated, advanced
surgical imaging solutions. The company's flagship product, IMRISneuro,
utilizes patented technology that allows a high field MRI scanner to be moved
in to the operating room on demand, providing imaging during the surgical
procedure without compromising patient safety. This unique and innovative
system has been validated by leading neurosurgeons for use in world-class
neuroscience centers.
For more information, visit www.imris.com.

SOURCE IMRIS Inc.

Susan McLeod, Manager, Marketing, Communications, IMRIS Inc., Tel: (204)
480-7094, Email: smcleod@imris.com